Oppenheimer analyst Colin Rusch maintains Wolfspeed (NYSE:WOLF) with a Outperform and lowers the price target from $118 to $115.
Intercept Pharma Summarizes Key Actions in Strategic Financial Repositioning
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced a summary of its actions to improve its capital position, including the recently announced private repurchases…